0001562180-23-006768.txt : 20230906
0001562180-23-006768.hdr.sgml : 20230906
20230906204835
ACCESSION NUMBER: 0001562180-23-006768
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230901
FILED AS OF DATE: 20230906
DATE AS OF CHANGE: 20230906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Landry Benjamin
CENTRAL INDEX KEY: 0001975281
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38993
FILM NUMBER: 231240794
MAIL ADDRESS:
STREET 1: C/O HEALTH CATALYST, INC.
STREET 2: 10897 SOUTH RIVER FRONT PARKWAY #300
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Health Catalyst, Inc.
CENTRAL INDEX KEY: 0001636422
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 453337483
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
BUSINESS PHONE: 801-708-6800
MAIL ADDRESS:
STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
FORMER COMPANY:
FORMER CONFORMED NAME: HQC Holdings, Inc.
DATE OF NAME CHANGE: 20150312
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-09-01
false
0001636422
Health Catalyst, Inc.
HCAT
0001975281
Landry Benjamin
10897 S. RIVER FRONT PARKWAY, #300
SOUTH JORDAN
UT
84095
false
true
false
false
General Counsel
false
Common Stock
2023-09-01
4
F
false
500.00
11.7765
D
29344.00
D
Common Stock
2023-09-06
4
S
false
1157.00
11.5231
D
28187.00
D
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 13, 2022 in accordance with Rule 10b5-1.
/s/ Benjamin Landry
2023-09-06